142 related articles for article (PubMed ID: 32075737)
21. Monitoring HIV DNA and cellular activation markers in HIV-infected humanized mice under cART.
Rochat MA; Schlaepfer E; Kuster SP; Li D; Audige A; Ivic S; Fahrny A; Speck RF
Virol J; 2018 Dec; 15(1):191. PubMed ID: 30558630
[TBL] [Abstract][Full Text] [Related]
22. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.
Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK
Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875
[TBL] [Abstract][Full Text] [Related]
23. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
J Virol; 2019 May; 93(10):. PubMed ID: 30842333
[TBL] [Abstract][Full Text] [Related]
24. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
25. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
26. CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation.
Wittner M; Dunay GA; Kummer S; Bockhorn M; Hüfner A; Schmiedel S; Degen O; van Lunzen J; Eberhard JM; Schulze Zur Wiesch J
J Acquir Immune Defic Syndr; 2018 Apr; 77(4):345-349. PubMed ID: 29293157
[TBL] [Abstract][Full Text] [Related]
27. CD32
Adams P; Fievez V; Schober R; Amand M; Iserentant G; Rutsaert S; Dessilly G; Vanham G; Hedin F; Cosma A; Moutschen M; Vandekerckhove L; Seguin-Devaux C
iScience; 2021 Jan; 24(1):101881. PubMed ID: 33364576
[TBL] [Abstract][Full Text] [Related]
28. The role of integration and clonal expansion in HIV infection: live long and prosper.
Anderson EM; Maldarelli F
Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600
[TBL] [Abstract][Full Text] [Related]
29. Infectious Virus Persists in CD4
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
[TBL] [Abstract][Full Text] [Related]
30. Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells.
Albanese M; Chen HR; Gapp M; Muenchhoff M; Yang HH; Peterhoff D; Hoffmann K; Xiao Q; Ruhle A; Ambiel I; Schneider S; Mejías-Pérez E; Stern M; Wratil PR; Hofmann K; Amann L; Jocham L; Fuchs T; Ulivi AF; Besson-Girard S; Weidlich S; Schneider J; Spinner CD; Sutter K; Dittmer U; Humpe A; Baumeister P; Wieser A; Rothenfusser S; Bogner J; Roider J; Knolle P; Hengel H; Wagner R; Laketa V; Fackler OT; Keppler OT
Cell Rep Med; 2024 Apr; 5(4):101483. PubMed ID: 38579727
[TBL] [Abstract][Full Text] [Related]
31. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.
Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N
J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901
[TBL] [Abstract][Full Text] [Related]
32. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.
Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M
Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
[TBL] [Abstract][Full Text] [Related]
34. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
35. X4-Tropic Latent HIV-1 Is Enriched in Peripheral Follicular Helper T Cells and Is Correlated with Disease Progression.
Yu F; Li Q; Chen X; Liu J; Li L; Li B; Liu B; Zhang J; Zhang X; Liu Z; Luo H; Tang XP; Cai W; Zhang H; Deng K
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666372
[TBL] [Abstract][Full Text] [Related]
36. Assays to Measure Latency, Reservoirs, and Reactivation.
Siliciano JD; Siliciano RF
Curr Top Microbiol Immunol; 2018; 417():23-41. PubMed ID: 29071475
[TBL] [Abstract][Full Text] [Related]
37. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
[TBL] [Abstract][Full Text] [Related]
38. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
39. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
[TBL] [Abstract][Full Text] [Related]
40. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
